id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1976-S-0001-0001,FDA,FDA-1976-S-0001,Methods for Conducting Recall Effectiveness Checks,Other,Recommendations,1999-12-30T05:00:00Z,1999,12,,,2018-03-16T18:14:29Z,,0,0,090000648051b0d1
FDA-1995-S-0039-0156,FDA,FDA-1995-S-0039,Report from FDA/CFSAN,Other,RPT-Report (outside of agency unless indicated),1999-12-28T05:00:00Z,1999,12,2009-01-02T05:00:00Z,,2016-09-30T14:23:06Z,,0,0,090000648055c3f6
FDA-1999-D-0009-0002,FDA,FDA-1999-D-0009,"Draft Guidance for Industry on Disclosing Information Provided to Advisory Committees in Connection With Open Advisory Committee Meetings Related to the Testing or Approval of New Drugs and Convened by the Center for Drug Evaluation and Research, Beginning on January 1, 2000; Availability",Notice,Notice of Availability,1999-12-23T05:00:00Z,1999,12,1999-12-23T05:00:00Z,2000-02-23T04:59:59Z,2014-07-16T13:42:06Z,,0,0,09000064804a59d0
FDA-1996-N-0006-0002,FDA,FDA-1996-N-0006,Notice of Proposed Rule re Additional Criteria and Procedures for Classifying Over-the-Counter Drugs as Generally Recognized as Safe and Effective and Not Misbranded,Proposed Rule,Notice of Proposed Rulemaking (NPRM),1999-12-20T05:00:00Z,1999,12,1999-12-20T05:00:00Z,2000-03-23T04:59:59Z,2015-05-05T15:10:01Z,,0,0,09000064804f9934
FDA-1998-D-0021-0002,FDA,FDA-1998-D-0021,FDA,Notice,NAD-Notice of Availability of Data,1999-12-15T05:00:00Z,1999,12,,,2008-05-16T21:18:01Z,,0,0,09000064805640ba
FDA-1999-M-0037-0001,FDA,FDA-1999-M-0037,Medical Devices; Availability of Safety and Effectiveness Summaries for PMA,Notice,Notice of Data Availability,1999-12-09T05:00:00Z,1999,12,,,2025-07-30T19:27:54Z,98-2263,0,0,09000064804a5d72
FDA-1980-N-0074-0068,FDA,FDA-1980-N-0074,"HFD-560 , Warner Lambert, Consumer Healthcare Prod., CTFA, FDC Reports",Other,MM-Memorandum of Meeting,1999-12-08T05:00:00Z,1999,12,,,2008-05-30T22:52:47Z,,0,0,09000064805bb4ba
FDA-1999-P-0059-0001,FDA,FDA-1999-P-0059,FDA/CDRH to Sanford J Lewis,Other,LET-Letter,1999-12-07T05:00:00Z,1999,12,,,2008-04-25T00:13:57Z,,0,0,09000064804a66c0
FDA-1999-N-0052-0001,FDA,FDA-1999-N-0052,FDA,Notice,NPR-Notice of Proposed Rule-Making,1999-12-03T05:00:00Z,1999,12,1999-12-03T05:00:00Z,2000-02-29T04:59:59Z,2008-04-25T00:14:43Z,,0,0,09000064804a6148
FDA-1999-D-0009-0001,FDA,FDA-1999-D-0009,"Guidance for Industry on the Disclosure of Materials Provided to Advisory
Committees in Connection with Open Advisory Committee Meetings Convened by the Center for Drug Evaluation and Research Beginning on January 1, 2000; Availability",Notice,Notice of Availability,1999-12-02T05:00:00Z,1999,12,1999-12-02T05:00:00Z,2000-02-29T04:59:59Z,2014-07-17T01:05:09Z,,0,0,09000064804a59ca
FDA-1991-N-0043-0012,FDA,FDA-1991-N-0043,FDA,Notice,N-Notice,1999-12-02T05:00:00Z,1999,12,,,2008-05-16T23:40:56Z,,0,0,090000648052af1a
FDA-1991-N-0033-0011,FDA,FDA-1991-N-0033,FDA,Notice,N-Notice,1999-12-02T05:00:00Z,1999,12,,,2008-05-16T23:40:25Z,,0,0,0900006480529612
FDA-1991-N-0043-0011,FDA,FDA-1991-N-0043,FDA,Notice,N-Notice,1999-12-02T05:00:00Z,1999,12,,,2008-05-16T23:40:54Z,,0,0,090000648052af16
FDA-1991-N-0033-0012,FDA,FDA-1991-N-0033,FDA,Notice,N-Notice,1999-12-02T05:00:00Z,1999,12,,,2008-05-16T23:40:19Z,,0,0,0900006480529614
FDA-2020-D-1958-0001,FDA,FDA-2020-D-1958,Guidance for Industry: Seafood HACCP Transition Guidance,Other,Guidance,1999-12-01T05:00:00Z,1999,12,2020-09-21T04:00:00Z,,2024-11-12T23:24:59Z,,1,0,0900006484869392
FDA-1999-D-3543-0001,FDA,FDA-1999-D-3543,Guidance for Industry: Seafood HACCP Transition Guidance,Other,Guidance,1999-12-01T05:00:00Z,1999,12,2020-09-30T04:00:00Z,,2024-11-12T23:26:15Z,,1,0,09000064848a586c
FDA-1998-N-0026-0003,FDA,FDA-1998-N-0026,FDA,Notice,NAD-Notice of Availability of Data,1999-11-30T05:00:00Z,1999,11,,,2008-05-16T21:28:55Z,,0,0,0900006480564966
FDA-1998-N-0026-0004,FDA,FDA-1998-N-0026,FDA,Notice,NAD-Notice of Availability of Data,1999-11-30T05:00:00Z,1999,11,,,2008-05-16T21:28:55Z,,0,0,0900006480564969
FDA-1997-N-0060-0002,FDA,FDA-1997-N-0060,Animal Drug Availability Act; Medicated Feed Mill Licenses,Notice,Notice of Final Rule,1999-11-24T00:00:00Z,1999,11,1999-11-19T05:00:00Z,,2025-05-15T16:25:41Z,99-29856,0,0,09000064805d0304
FDA-1994-P-0041-0002,FDA,FDA-1994-P-0041,"Food Labeling: Trans Fatty Acids in Nutrition Labeling, Nutrient Content Claims, and Health Claims; Pages 1-100",Proposed Rule,NPR-Notice of Proposed Rule-Making,1999-11-17T05:00:00Z,1999,11,1999-11-17T05:00:00Z,2000-02-16T04:59:59Z,2010-02-12T19:30:22Z,,0,0,09000064804fe332
FDA-1994-P-0041-0001,FDA,FDA-1994-P-0041,"Food Labeling: Trans Fatty Acids in Nutrition Labeling, Nutrient Content Claims, and Health Claims; Pages 101-148",Proposed Rule,NPR-Notice of Proposed Rule-Making,1999-11-17T05:00:00Z,1999,11,1999-11-17T05:00:00Z,2000-02-16T04:59:59Z,2010-02-12T19:28:39Z,,0,0,09000064804fda73
FDA-1999-P-0127-0001,FDA,FDA-1999-P-0127,FDA/DMB to Quinn Consulting Services,Other,ACK-Acknowledgement Letter,1999-11-09T05:00:00Z,1999,11,,,2008-04-25T00:18:38Z,,0,0,09000064804aea0a
FDA-1978-N-0018-0437,FDA,FDA-1978-N-0018,Letter from FDA/CDER to The Procter & Gamble Company,Other,Letter(s),1999-11-08T05:00:00Z,1999,11,,,2019-07-26T12:27:36Z,,0,0,090000648055a6a5
FDA-1999-D-0081-0001,FDA,FDA-1999-D-0081,"Draft ""Guidance for Industry: Supplemental Guidance on Testing for Replication Competent Retrovirus in Retroviral Vector Based Gene Therapy Products and During Follow-up of Patients in Clinical Trials Using Retroviral Vectors;"" Availability",Notice,Notice of Data Availability,1999-11-03T05:00:00Z,1999,11,1999-11-03T05:00:00Z,2000-02-02T04:59:59Z,2025-07-01T20:17:52Z,99-28560,0,0,09000064804a694a
FDA-1999-P-0108-0001,FDA,FDA-1999-P-0108,"Notice - Gastroenterology-Urology Devices; Denial of Request for Change in Classification
of Fiber Optic Light Sources",Notice,ND-Notice of Denial,1999-11-03T00:00:00Z,1999,11,1999-11-03T05:00:00Z,,2025-05-16T19:01:53Z,,0,0,09000064804ae5e8
FDA-1995-S-0039-0155,FDA,FDA-1995-S-0039,Report from FDA/CFSAN,Other,RPT-Report (outside of agency unless indicated),1999-11-02T05:00:00Z,1999,11,2009-01-02T05:00:00Z,,2016-09-30T14:23:06Z,,0,0,090000648055c3f2
FDA-1996-P-0246-0022,FDA,FDA-1996-P-0246,"Interim Response Letter from FDA CFSAN to Brach and Brock Confections, Hershey Foods Corporation",Other,Letter(s),1999-11-01T05:00:00Z,1999,11,2014-02-20T05:00:00Z,,2014-02-20T14:23:41Z,,0,0,0900006480503988
FDA-1984-F-0029-0001,FDA,FDA-1984-F-0029,FDA,Notice,NFR-Notice of Final Rule,1999-10-29T04:00:00Z,1999,10,1999-10-29T04:00:00Z,1999-11-30T04:59:59Z,2008-05-30T22:52:31Z,,0,0,09000064805a81d9
FDA-1999-D-0110-0003,FDA,FDA-1999-D-0110,Medical Gloves; Draft Guidance Manual; Availability; Extension of Comment Period,Notice,Extension of Comment Period,1999-10-29T04:00:00Z,1999,10,1999-10-29T04:00:00Z,2000-01-28T04:59:59Z,2025-06-17T16:32:54Z,99-28110,0,0,09000064804ae620
FDA-1999-D-0066-0001,FDA,FDA-1999-D-0066,Guidance for Industry: Reducing Microbial Food Safety Hazards for Sprouted Seeds and Guidance for Industry: Sampling and Microbial Testing of Spent Irrigation Water During Sprout Production,Notice,Notice of Data Availability,1999-10-28T04:00:00Z,1999,10,1999-10-28T04:00:00Z,1999-12-14T04:59:59Z,2025-07-19T09:00:20Z,99-28016,0,0,09000064804a67c8
FDA-1996-P-0309-0022,FDA,FDA-1996-P-0309,"Interim Response Letter from FDA/CFSAN to Brach and Brock Confections, Hershey Foods Corporation, and Nestle USA, Inc., King and Spalding",Other,Letter(s),1999-10-26T04:00:00Z,1999,10,2014-02-20T05:00:00Z,,2014-02-20T12:40:54Z,,0,0,0900006480504ca1
FDA-1999-P-0126-0004,FDA,FDA-1999-P-0126,FDA/DMB to Pharmacia & Upjohn Inc.,Other,CR-Correction,1999-10-26T04:00:00Z,1999,10,,,2008-04-25T00:19:51Z,,0,0,09000064804ae9ee
FDA-1999-P-0126-0003,FDA,FDA-1999-P-0126,FDA/DMB to Pharmacia & Upjohn,Other,ACK-Acknowledgement Letter,1999-10-26T04:00:00Z,1999,10,,,2008-04-25T00:19:51Z,,0,0,09000064804ae9ed
FDA-1999-N-0099-0001,FDA,FDA-1999-N-0099,FDA,Notice,NM-Notice of Meeting,1999-10-25T04:00:00Z,1999,10,1999-10-25T04:00:00Z,2000-01-14T04:59:59Z,2009-10-13T15:28:32Z,,0,0,09000064804a6b42
FDA-1999-N-0035-0001,FDA,FDA-1999-N-0035,Jay Marcus; Proposal to Debar; Opportunity for a Hearing,Notice,Notice of Opportunity of Hearing,1999-10-21T04:00:00Z,1999,10,,,2024-10-22T17:56:31Z,99–26938,0,0,09000064804a5d45
FDA-1998-N-0041-0004,FDA,FDA-1998-N-0041,Biological Products Regulated Under Section 351 of the Public Health Services Act; implementation of Biologics License; Elimination of Establishment License and Product License,Notice,Notice of Final Rule,1999-10-20T04:00:00Z,1999,10,,,2026-01-30T03:40:40Z,99-27159,0,0,090000648056e5ae
FDA-1999-N-0067-0005,FDA,FDA-1999-N-0067,Agency Information Collection Activities; Announcement of OMB Approval; Regulations Under the Federal Import Milk Act,Notice,Notice of Approval,1999-10-13T04:00:00Z,1999,10,,,2024-10-10T15:05:25Z,99-26223,0,0,09000064804a683e
FDA-1995-S-0039-0158,FDA,FDA-1995-S-0039,Report from FDA/CFSAN,Other,RPT-Report (outside of agency unless indicated),1999-10-13T04:00:00Z,1999,10,2009-01-02T05:00:00Z,,2016-09-30T14:23:07Z,,0,0,090000648055c3fa
FDA-1999-D-0011-0001,FDA,FDA-1999-D-0011,"Guidance for Industry: Chemistry, Manufacturing and Control Changes to an Approved NADA or ANADA; Availability",Notice,Notice of Data Availability,1999-10-08T04:00:00Z,1999,10,1999-10-08T04:00:00Z,1999-12-16T04:59:59Z,2025-06-04T09:00:09Z,99-25492,0,0,09000064804a59fd
FDA-1999-D-0065-0003,FDA,FDA-1999-D-0065,Advisory Committee for Reproductive Health Drugs; Notice of Meeting,Notice,Meeting,1999-10-04T04:00:00Z,1999,10,,,2025-06-03T15:46:14Z,99-25228,0,0,09000064804a67be
FDA-1997-N-0057-0001,FDA,FDA-1997-N-0057,Suitability Determination for Donors of Human Cellular and Tissue-Based Products - Notice of Proposed Rule,Notice,NPR-Notice of Proposed Rule-Making,1999-10-01T04:00:00Z,1999,10,1999-09-30T04:00:00Z,1999-12-30T04:59:59Z,2010-10-06T21:13:49Z,,0,0,09000064805cfd41
FDA-1995-S-0039-0154,FDA,FDA-1995-S-0039,Report from FDA/CFSAN,Other,RPT-Report (outside of agency unless indicated),1999-09-28T04:00:00Z,1999,9,2009-01-02T05:00:00Z,,2016-09-30T14:23:06Z,,0,0,090000648055c3ef
FDA-1998-P-0084-0003,FDA,FDA-1998-P-0084,"Citizen Petition Denial from FDA CDER to AndrxPharmaceuticals, Inc.",Other,Denial of Petition,1999-09-23T04:00:00Z,1999,9,,,2024-07-17T16:04:00Z,,0,0,0900006480584d87
FDA-1999-N-0031-0002,FDA,FDA-1999-N-0031,"Current Good Manufacturing Practices for Positron Emission Tomography
Drug Products; Preliminary Draft Regulations; Availability",Notice,Notice of Data Availability,1999-09-23T04:00:00Z,1999,9,1999-09-22T04:00:00Z,1999-10-14T03:59:59Z,2025-03-19T19:39:19Z,02-7728,0,0,09000064804a5ce7
FDA-1999-N-0031-0001,FDA,FDA-1999-N-0031,Current Good Manufacturing Practice for Positron Emission Tomography Drug Products; Preliminary Draft Proposed Rule; Availability,Notice,Notice of Data Availability,1999-09-23T04:00:00Z,1999,9,2002-04-01T05:00:00Z,2002-06-06T03:59:59Z,2025-03-19T19:31:46Z,02-7728,0,0,09000064804a5ce4
FDA-1998-P-0018-0002,FDA,FDA-1998-P-0018,Citizen Petition Approval from FDA CDER to King & Spalding,Other,Approval,1999-09-23T04:00:00Z,1999,9,,,2024-07-12T16:29:21Z,,0,0,0900006480563c50
FDA-1980-N-0074-0067,FDA,FDA-1980-N-0074,"FDA/CDER to Kleinfeld, Kaplan and Becker",Other,PDN-Petition Denial,1999-09-14T04:00:00Z,1999,9,,,2008-05-30T22:53:22Z,,0,0,09000064805bb4a5
FDA-1999-P-0126-0002,FDA,FDA-1999-P-0126,FDA/CDER to Glaxo Wellcome Inc,Other,LET-Letter,1999-09-14T04:00:00Z,1999,9,,,2008-04-25T00:19:51Z,,0,0,09000064804ae9eb
FDA-1991-N-0033-0010,FDA,FDA-1991-N-0033,FDA,Notice,N-Notice,1999-09-09T04:00:00Z,1999,9,1999-09-09T04:00:00Z,1999-11-23T04:59:59Z,2008-05-16T23:40:20Z,,0,0,0900006480529457
FDA-1998-N-0010-0001,FDA,FDA-1998-N-0010,FDA,Notice,N-Notice,1999-09-09T04:00:00Z,1999,9,1999-09-09T04:00:00Z,1999-10-01T03:59:59Z,2008-05-16T21:28:44Z,,0,0,09000064805590b0
FDA-1991-N-0043-0010,FDA,FDA-1991-N-0043,FDA,Notice,N-Notice,1999-09-09T04:00:00Z,1999,9,1999-09-09T04:00:00Z,1999-11-23T04:59:59Z,2008-05-16T23:40:47Z,,0,0,090000648052aeb8
FDA-1991-N-0043-0009,FDA,FDA-1991-N-0043,FDA,Notice,N-Notice,1999-09-09T04:00:00Z,1999,9,1999-09-09T04:00:00Z,1999-11-23T04:59:59Z,2008-05-16T23:40:56Z,,0,0,090000648052aeb5
FDA-1991-N-0033-0009,FDA,FDA-1991-N-0033,FDA,Notice,N-Notice,1999-09-09T04:00:00Z,1999,9,1999-09-09T04:00:00Z,1999-11-23T04:59:59Z,2008-05-16T23:40:29Z,,0,0,0900006480529456
FDA-1996-N-0028-0008,FDA,FDA-1996-N-0028,"Dietary Supplements; Center for Food Safety and Applied Nutrition (Small Business Outreach CGMPs in the Dietary Supplement Industry); Public Meeting Held September 28 and October 21, 1999), 9/3/1999 - Annoucement of Public Meeting",Notice,NM-Notice of Meeting,1999-09-08T04:00:00Z,1999,9,1999-09-08T04:00:00Z,1999-11-22T04:59:59Z,2009-09-24T04:50:05Z,,0,0,09000064804fb8ac
FDA-1998-D-0098-0003,FDA,FDA-1998-D-0098,FDA,Notice,NM-Notice of Meeting,1999-08-26T04:00:00Z,1999,8,,,2008-05-16T21:23:18Z,,0,0,0900006480586e5b
FDA-1999-N-0134-0002,FDA,FDA-1999-N-0134,FDA,Notice,NM-Notice of Meeting,1999-08-24T04:00:00Z,1999,8,1999-08-24T04:00:00Z,1999-10-26T03:59:59Z,2008-04-25T00:16:54Z,,0,0,09000064804aeb87
FDA-1999-N-0113-0007,FDA,FDA-1999-N-0113,FDA,Notice,NM-Notice of Meeting,1999-08-24T04:00:00Z,1999,8,1999-08-24T04:00:00Z,1999-10-26T03:59:59Z,2008-04-25T00:17:45Z,,0,0,09000064804ae6aa
FDA-1999-N-0113-0006,FDA,FDA-1999-N-0113,FDA,Notice,NM-Notice of Meeting,1999-08-24T04:00:00Z,1999,8,1999-08-24T04:00:00Z,1999-10-26T03:59:59Z,2008-04-25T00:17:45Z,,0,0,09000064804ae6a9
FDA-1999-H-0144-0001,FDA,FDA-1999-H-0144,HHS/FDA/CDER Administrative Compliant for Civil Penalties - Notice of Opportunity of Hearing,Notice,NPH-Notice of Opportunity of Hearing,1999-08-19T04:00:00Z,1999,8,,,2009-07-13T22:58:04Z,,0,0,09000064804aef18
FDA-1999-F-0118-0002,FDA,FDA-1999-F-0118,"Food Additives Permitted for Direct Addition to Food for Human Consumption;
Sucralose",Notice,Notice of Final Rule,1999-08-18T04:00:00Z,1999,8,1999-08-12T04:00:00Z,1999-09-14T03:59:59Z,2025-04-16T14:57:22Z,99 20888,0,0,09000064804ae93f
FDA-1999-N-0067-0004,FDA,FDA-1999-N-0067,Agency Information Collection Activities; Submission for OMB Review; Comment Request; Regulations Under the Federal Import Milk Act; Correction,Notice,Correction,1999-08-18T04:00:00Z,1999,8,,,2024-10-10T15:02:38Z,99-20793,0,0,09000064804a683c
FDA-1999-F-0021-0001,FDA,FDA-1999-F-0021,"Notice of Filing of Food Additive Petition (FAP 9M4673), Caudill Seed Co., Inc.",Notice,NFL-Notice of Filing,1999-08-16T04:00:00Z,1999,8,,,2011-07-20T15:47:39Z,,0,0,09000064804a5ac3
FDA-1999-P-0125-0001,FDA,FDA-1999-P-0125,"Acknowledgement Letter from FDA DMB to Palmer & Dodge, LLP",Other,Acknowledgement Letter/Receipt,1999-08-13T00:00:00Z,1999,8,,,2025-05-23T00:01:41Z,,0,0,09000064804ae9c2
FDA-1999-D-0032-0001,FDA,FDA-1999-D-0032,Medical Devices; Final Guidance on Quality Systems Regulation Information for Various Premarket Submissions; Availability,Notice,Notice of Data Availability,1999-08-11T04:00:00Z,1999,8,,,2025-06-11T17:04:45Z,03-2375,0,0,09000064804a5d15
FDA-1999-D-0128-0001,FDA,FDA-1999-D-0128,Draft Guidance for Industry: Cooperative Manufacturing Arrangements for Licensed Biologics”; Availability,Notice,NAD-Notice of Availability of Data,1999-08-11T04:00:00Z,1999,8,1999-08-11T04:00:00Z,1999-10-05T03:59:59Z,2025-08-06T09:00:11Z,,0,0,09000064804aea26
FDA-1998-N-0068-0009,FDA,FDA-1998-N-0068,HFA-250,Notice,NAL-Notice of Approval,1999-08-11T04:00:00Z,1999,8,,,2008-05-16T21:31:26Z,,0,0,0900006480571d55
FDA-1991-F-0012-0002,FDA,FDA-1991-F-0012,FDA,Notice,NCR-Notice of Correction,1999-08-10T04:00:00Z,1999,8,,,2008-05-16T23:37:55Z,,0,0,0900006480525eed
FDA-1999-N-0137-0003,FDA,FDA-1999-N-0137,Agency Information Collection Activities; Announcement of OMB Approval; Infant Formula Recall Regulations,Notice,Notice of Approval,1999-08-09T04:00:00Z,1999,8,,,2024-10-07T20:14:41Z,99-20258,0,0,09000064804aedc9
FDA-1985-N-0022-0010,FDA,FDA-1985-N-0022,Notice of Proposed Rulemaking re Drug Price Competition & Patent Term Restoration ACT 1984,Proposed Rule,Notice of Proposed Rulemaking (NPRM),1999-08-09T04:00:00Z,1999,8,1999-08-09T04:00:00Z,1999-11-05T04:59:59Z,2016-02-26T19:20:20Z,,0,0,09000064805b3c13
FDA-1999-N-0115-0001,FDA,FDA-1999-N-0115,Global Harmonization Task Force; Draft Document on Proposal for Reporting of Use Errors with Medical Devices; Availability,Notice,Notice of Data Availability,1999-08-09T04:00:00Z,1999,8,1999-08-05T04:00:00Z,1999-09-08T03:59:59Z,2024-10-16T20:18:24Z,99-20140,0,0,09000064804ae8f8
FDA-1999-N-0137-0004,FDA,FDA-1999-N-0137,Agency Information Collection Activities; Announcement of OMB Approval; Infant Formula Recall Regulations,Notice,Notice of Approval,1999-08-09T04:00:00Z,1999,8,,,2024-10-08T12:28:45Z,99-20258,0,0,09000064804aedcb
FDA-1999-F-0120-0001,FDA,FDA-1999-F-0120,"Hercules, Inc.; Filing of Food Additive Petition",Notice,Notice of Filing,1999-08-09T00:00:00Z,1999,8,,,2025-05-02T17:57:26Z,99-20090,0,0,09000064804ae95c
FDA-1999-D-0110-0001,FDA,FDA-1999-D-0110,Medical Gloves; Draft Guidance Manual; Availability,Notice,Notice of Data Availability,1999-08-05T04:00:00Z,1999,8,1999-08-05T04:00:00Z,1999-10-03T03:59:59Z,2025-06-18T09:00:04Z,99-19192,0,0,09000064804ae60c
FDA-1999-N-0141-0004,FDA,FDA-1999-N-0141,FDA,Notice,NM-Notice of Meeting,1999-08-05T04:00:00Z,1999,8,,,2008-04-25T00:20:16Z,,0,0,09000064804aee50
FDA-1999-N-0141-0003,FDA,FDA-1999-N-0141,FDA,Notice,NM-Notice of Meeting,1999-08-05T04:00:00Z,1999,8,,,2008-04-25T00:20:16Z,,0,0,09000064804aee4f
FDA-1999-D-0110-0002,FDA,FDA-1999-D-0110,Medical Gloves; Draft Guidance Manual; Availability,Notice,Notice of Data Availability,1999-08-05T04:00:00Z,1999,8,1999-08-05T04:00:00Z,1999-10-03T03:59:59Z,2025-06-17T15:55:32Z,99-19192,0,0,09000064804ae61c
FDA-1999-D-0049-0001,FDA,FDA-1999-D-0049,Changes to an Approved NDA or ANDA; Proposed Rule and Draft Companion Guidance; Public Meeting,Notice,NM-Notice of Meeting,1999-08-05T00:00:00Z,1999,8,,,2025-05-21T22:37:52Z,,0,0,09000064804a6017
FDA-1978-N-0018-0436,FDA,FDA-1978-N-0018,"Letter from FDA/CDER to The Cosmetic, Toiletry & Fragrance Association",Other,Letter(s),1999-08-03T04:00:00Z,1999,8,,,2019-07-25T18:01:31Z,,0,0,090000648055a696
FDA-1999-N-0067-0003,FDA,FDA-1999-N-0067,Agency Information Collection Activities; Submission for OMB Review; Comment Request; Regulations Under the Federal Import Milk Act; Correction,Notice,Correction,1999-08-03T04:00:00Z,1999,8,,,2024-10-10T15:00:30Z,99-19688,0,0,09000064804a683b
FDA-1999-N-0067-0002,FDA,FDA-1999-N-0067,Agency Information Collection Activities; Submission for 0MB Review; Comment Request; Regulations Under the Federal Import Milk Act,Notice,30 Day Proposed Information Collection,1999-07-27T04:00:00Z,1999,7,1999-07-26T04:00:00Z,1999-08-26T03:59:59Z,2025-03-18T13:56:04Z,99-18927,0,0,09000064804a683a
FDA-1999-N-0095-0003,FDA,FDA-1999-N-0095,Agency Information Collection Activities; Announcement of OMB Approval; Food Labeling: Notification Procedures for Statements on Dietary Supplements,Notice,Notice of Approval,1999-07-22T04:00:00Z,1999,7,,,2024-11-19T13:34:09Z,99-18694,0,0,09000064804a6ae4
FDA-1999-N-0015-0001,FDA,FDA-1999-N-0015,Topical Antifungal Drug Products for Over-the-Counter Human Use; Proposed Amendment of Final Monograph,Notice,NPR-Notice of Proposed Rule-Making,1999-07-22T04:00:00Z,1999,7,1999-07-22T04:00:00Z,1999-10-21T03:59:59Z,2024-10-16T15:56:13Z,99-18699,0,0,09000064804a5a6f
FDA-1999-N-0016-0002,FDA,FDA-1999-N-0016,Agency Information Collection Activities; Announcement of OMB Approval; Premarket Notification for a New Dietary Ingredient,Notice,Notice of Approval,1999-07-22T04:00:00Z,1999,7,,,2025-03-18T11:52:30Z,99-18696,0,0,09000064804a5a80
FDA-1997-D-0009-0003,FDA,FDA-1997-D-0009,FDA,Notice,NAD-Notice of Availability of Data,1999-07-15T04:00:00Z,1999,7,,,2008-05-16T21:59:17Z,,0,0,09000064805c9a38
FDA-1999-P-0043-0001,FDA,FDA-1999-P-0043,Acknowledgment Letter from FDA DDM to Mikart Inc.,Other,Acknowledgement Letter/Receipt,1999-07-09T04:00:00Z,1999,7,,,2017-04-26T18:14:14Z,,0,0,09000064804a5f3d
FDA-1999-N-0096-0002,FDA,FDA-1999-N-0096,Agency Information Collection Activities; Submission for OMB Review; Comment Request; Labeling Requirements for Color Additives (Other Than Hair Dyes) and Petitions,Notice,30 Day Proposed Information Collection,1999-07-08T04:00:00Z,1999,7,1999-07-08T04:00:00Z,1999-08-10T03:59:59Z,2024-11-19T19:44:29Z,99-17242,0,0,09000064804a6af0
FDA-1999-N-0013-0002,FDA,FDA-1999-N-0013,Agency Information Collection Activities; Submission for OMB Review; Comment Request; Extralabel Drug Use in Animals,Notice,30 Day Proposed Information Collection,1999-07-02T04:00:00Z,1999,7,1999-06-30T04:00:00Z,1999-07-31T03:59:59Z,2024-11-19T17:02:35Z,99-16593,0,0,09000064804a5a4d
FDA-1999-N-0141-0001,FDA,FDA-1999-N-0141,FDA,Notice,NPR-Notice of Proposed Rule-Making,1999-06-30T04:00:00Z,1999,6,1999-06-30T04:00:00Z,1999-09-14T03:59:59Z,2008-04-25T00:20:16Z,,0,0,09000064804aee46
FDA-1999-N-0141-0002,FDA,FDA-1999-N-0141,FDA,Notice,NPR-Notice of Proposed Rule-Making,1999-06-30T04:00:00Z,1999,6,1999-06-30T04:00:00Z,1999-09-14T03:59:59Z,2008-04-25T00:20:16Z,,0,0,09000064804aee49
FDA-1999-D-0050-0001,FDA,FDA-1999-D-0050,Draft Guidance for Industry on Bioavailability and Bioequivalence Studies for Nasal Aerosols and Nasal Sprays for Local Action; Availability,Notice,Notice of Data Availability,1999-06-25T04:00:00Z,1999,6,1999-06-25T04:00:00Z,1999-09-23T03:59:59Z,2025-06-05T09:00:08Z,99-16140,0,0,09000064804a6066
FDA-1996-N-0028-0007,FDA,FDA-1996-N-0028,"Dietary Supplements; Center for Food Safety and Applied Nutrition (Small Business Outreach); Public Meeting Held July 12, 1999, 6/18/1999",Notice,NM-Notice of Meeting,1999-06-23T04:00:00Z,1999,6,1999-06-23T04:00:00Z,1999-08-13T03:59:59Z,2009-10-09T03:24:35Z,,0,0,09000064804fb89f
FDA-1999-N-0051-0003,FDA,FDA-1999-N-0051,FDA,Notice,NM-Notice of Meeting,1999-06-23T04:00:00Z,1999,6,1999-06-23T04:00:00Z,1999-08-13T03:59:59Z,2008-04-25T00:14:28Z,,0,0,09000064804a60e6
FDA-1999-N-0051-0002,FDA,FDA-1999-N-0051,FDA,Notice,NCR-Notice of Correction,1999-06-17T04:00:00Z,1999,6,,,2008-04-25T00:14:27Z,,0,0,09000064804a60d3
FDA-1999-N-0007-0001,FDA,FDA-1999-N-0007,Obstetrical and Gynecological Devices; Proposed Classification of Female Condoms,Proposed Rule,Notice of Proposed Rulemaking (NPRM),1999-06-16T04:00:00Z,1999,6,1999-06-10T04:00:00Z,1999-09-09T03:59:59Z,2024-10-10T19:38:34Z,99-14653,0,0,09000064804a59a9
FDA-1999-D-0010-0001,FDA,FDA-1999-D-0010,Draft Guidance for Industry on in Vivo Pharmacokinetics and Bioavailability Studies and in Vitro Dissolution Testing for Levothyroxine Sodium Tablets; Availability,Notice,Notice of Data Availability,1999-06-15T00:00:00Z,1999,6,1999-06-15T00:00:00Z,1999-08-10T03:59:59Z,2025-05-28T09:01:12Z,99-14751,0,0,09000064804a59e3
FDA-1999-P-0079-0001,FDA,FDA-1999-P-0079,FDA/DMB to Orthopedic Surgical Manufacturers Association,Other,ACK-Acknowledgement Letter,1999-06-14T04:00:00Z,1999,6,,,2008-04-25T00:00:57Z,,0,0,09000064804a6902
FDA-1995-S-0039-0140,FDA,FDA-1995-S-0039,Report from FDA/CFSAN,Other,RPT-Report,1999-06-11T04:00:00Z,1999,6,2008-12-03T05:00:00Z,,2016-09-30T14:23:00Z,,0,0,090000648055c3ba
FDA-1999-D-0065-0002,FDA,FDA-1999-D-0065,Reviewer Guidance Evaluation of Human Pregnancy Outcome Data,Supporting & Related Material,Guidance,1999-06-10T04:00:00Z,1999,6,,,2025-06-03T15:02:38Z,,0,0,09000064804a67b9
FDA-1999-D-0065-0001,FDA,FDA-1999-D-0065,Draft Guidance for Reviewers on Evaluation of Human Pregnancy Outcome Data; Availability,Notice,Notice of Data Availability,1999-06-10T04:00:00Z,1999,6,1999-06-10T04:00:00Z,1999-09-03T03:59:59Z,2025-06-04T09:00:09Z,99-14149,0,0,09000064804a67b8
FDA-1991-F-0012-0001,FDA,FDA-1991-F-0012,FDA,Notice,NFR-Notice of Final Rule,1999-06-10T04:00:00Z,1999,6,1999-06-10T04:00:00Z,1999-07-07T03:59:59Z,2008-05-16T23:37:55Z,,0,0,0900006480525e47